Pharmaceutical preparations (e.g., capsules, liniments, ointments, tablets) manufacturing · New York

SpecGx-Hobart

Hobart, NY · ~438 workers · 2 years of OSHA Injury Tracking Application data.

C
Average Safety Record
3.4
Avg TCR
3.3
Industry avg
0
Fatalities
Subscribe to safety-record updates (RSS)

The verdict

SpecGx-Hobart runs at 102% of its industry's injury rate - about level with the typical Pharmaceutical preparations (e.g., capsules, liniments, ointments, tablets) manufacturing workplace, earning a grade C.

SpecGx-Hobart: 3.4 TCR = 102% of Pharmaceutical preparations (e.g., capsules, liniments, ointments, tablets) manufacturing BLS 3.3 · 2y Form 300A (see methodology below)

SpecGx-Hobart safety composite

SpecGx-Hobart scores strongest on fatalities (safer than 50% of same-industry peers) and weakest on total case rate (tcr) (safer than 24%), blended into one 0-100 breakdown against same-industry peers. A missing measure drops out and redistributes its weight rather than deflating the score. This is a per-dimension breakdown, distinct from the single letter grade above it (which weights TCR alone against the BLS industry benchmark).

F

31/100

Percentile-weighted across 3 of 3 measures

Total Case Rate (TCR)
F 3.37 per 100 workers

Safer than 24% of industry peers

DART rate
F 1.94 per 100 workers

Safer than 24% of industry peers

Fatalities
D 0

Safer than 50% of industry peers

Benchmarked live against every credibly-rated employer in the same NAICS industry code in the current OSHA extract (a segment must have at least 8 rated peers to benchmark). Not a legal or compliance determination; PlainSafetyScore's own weighting (TCR 40%, DART 35%, fatalities 25%).

TCR Δ

−0.4

2022→2023

SpecGx-Hobart injury rate improved

SpecGx-Hobart's TCR fell 0.4 from 3.6 in 2022 to 3.2 in 2023. Peak filing year was 2022 at 3.6 TCR. In 2023, DART was 0.58× this establishment's average TCR (severity share of cases).

2022=3.6 · 2023=3.2

OSHA ITA Form 300A scorecard

Establishment book 325412 · Hobart, NY ABOVE-IND · MID

Grade C · TCR 3.4 · 102% of ind

  • DART 1.9 DART
  • RANK #41/64
  • PHOTO Fresenius Kabi - Wil…
  • BOOK 2y book
  • INJ 22 inj
  • SIZE ~438 FTE

Nearest TCR peer: Fresenius Kabi - Wilson, NC Production Unit (0.0 TCR gap)

Read with this employer → · Industry book → · New York employers → · Look up another →

SpecGx-Hobart in the TCR neighbourhood

Average Total Case Rate among this establishment and nearest same-industry peers

TCR

What this shows SpecGx-Hobart averages 3.4 TCR (102% of the Pharmaceutical preparations (e.g., capsules, liniments, ointments, tablets) manufacturing BLS benchmark).

Source U.S. Department of Labor, OSHA Injury Tracking Application (Form 300A) As of 2026-08-25

SpecGx-Hobart TCR series: 2022=3.6 · 2023=3.2 · BLS 3.3

Where SpecGx-Hobart falls in its industry

855 Pharmaceutical preparations (e establishments

Safer than 24% of graded establishments in this industry, whose median TCR is 1.6.

More dangerous than peersSafer than peers

Narrower to New York alone (the establishments it most directly competes with for workers and contracts): ranked #41 safest of 64 Pharmaceutical preparations (e employers in New York.

SpecGx-Hobart (438 employees, TCR 3.4) among 29 same-industry peers, split at the industry median of 171 employees and a TCR of 1.6 2×2 strategic matrix plotting 30 entities by Average employees (X) and Total Case Rate (Y), with a crosshair dividing the plot into four quadrants. Larger & higher-riskSmaller & higher-riskLarger & saferSmaller & safer than peers 01,0002,0003,0004,000 051015 Average employees Total Case Rate SpecGx-Hobart
SpecGx-Hobart (438 employees, TCR 3.4) among 29 same-industry peers, split at the industry median of 171 employees and a TCR of 1.6

SpecGx-Hobart has more employees than the Pharmaceutical preparations (e.g., capsu median and a higher injury rate than the industry's median TCR of 1.6. Workforce size and injury rate do not always move together within the same industry -- some of its smaller peers run higher rates than its larger ones, and vice versa.

Year-by-Year Safety Data

Year TCR DART Injuries Illnesses Fatalities
2023 3.2 1.9 10 3 0
2022 3.6 3.1 12 2 0

OSHA ITA peer cross-reference

Establishment peer ledger

325412 · NY · Hobart

855 Pharmaceutical preparations (e.g., capsules, liniments, ointments, tablets) manufacturing employers nationwide with a credible TCR · 21,008 rated employers in New York with headcount on file · 4 cross-state NAT-TCR peers · 4 cross-state NAT-SIZE peers. Closest matches by relationship code are listed below.

Rel Establishment Metric
NAICS-TCR Fresenius Kabi - Wilson, NC Production Unit 3.4 TCR
NAICS-TCR Dak Pak 3.4 TCR
NAICS-TCR Rasi Laboratories, Inc. 3.4 TCR
NAICS-TCR LNK - 60 Arkay 3.4 TCR
STATE-SIZE Thomson Reuters - Rochester 438 FTE
STATE-SIZE New York Headquarters 437 FTE
STATE-SIZE Sciegen Pharmaceuticals Inc. 437 FTE
STATE-SIZE McGard llc 437 FTE
CITY-NEAR SpecGx LLC- Hobart Facility 472 FTE
NAT-TCR Oakland Park Clr Ctr Outlet - #931 3.4 TCR
NAT-TCR Graco Inc. - Rogers Distribution Center 3.4 TCR
NAT-TCR Denver Intermodal Express Inc 3.4 TCR
NAT-TCR LINC 5002 (Ankeny - F) 3.4 TCR
NAT-SIZE USM Store #553 (Market Street) 438 FTE
NAT-SIZE Roberts Tours and Transportation Inc Oahu 438 FTE
NAT-SIZE Magna Dexsys 438 FTE
NAT-SIZE SLC-ODFL 438 FTE

Rel codes: NAICS-TCR · STATE-SIZE · CITY-NEAR · NAT-TCR/NAT-SIZE cross-state. Read with this employer →

Data Source: OSHA Injury Tracking Application (ITA), mandatory establishment-level injury/illness reports. Grades compare employer Total Case Rate (TCR) to BLS IIF industry benchmarks. Data covers years reported by this establishment: 2023, 2022. This is publicly available government data - not a legal determination of workplace conditions.

Read our methodology - how this data is sourced, computed, and verified.

Data sourced from official public datasets. See our methodology for details.